menu

Fisher Center Discovery Program (FCDP)

Fisher Center Discovery Program

To develop excellence in clinical research regarding environmental infectious pathogens, the Center has created the Fisher Center Discovery Program (FCDP).  Goals of the FCDP include:

  • Funding of grants for clinical research related to environmental infectious diseases
  • Provision of resources for studies that lack traditional funding mechanisms
  • Promotion of cross-disciplinary collaborative research
  • Provision of mentoring opportunities for early career investigators

We award a maximum of $50,000 to individual Johns Hopkins researchers during a single annual grant cycle.  Notifications about the grants opportunity are distributed by email via individual schools of the Johns Hopkins University and pertinent faculty list serves.  All full-time faculty members of the Johns Hopkins University, especially junior faculty, are encouraged to apply. For questions concerning the grants program, please email fishercenter@jhmi.edu or call 443-287-4840.

These Discovery Program grants are possible through the generous support of Sherrilyn Fisher.

2020 Fisher Center Discovery Program Grant Cycle

The 2020 grant cycle will commence with release of the Request for Application (RFA) on Tuesday, June 25, 2019.

Applicants are strongly encouraged to review the document FCDP Application Guidelines 2020.

Letter of Intent submission deadline Monday, August 19, 2019

Full Application submission deadline Monday, September 23, 2019

 

2020 Document Library

FCDP Request for Application (RFA) 2020

FCDP Application Guidelines 2020

FCDP Frequently Asked Questions 2020

FCDP Letter of Intent form 2020

FCDP Application 2020

FCDP Budget Template 2020

FCDP 2020 Time Line

FCDP Prior Awarded Projects

Principal Investigators were Johns Hopkins University faculty at the time of award. Co-investigators are not listed.

YearPrincipal InvestigatorProject Title
2018Anthony K. L. Leung, PhDUnderstanding how virus virulence is regulated by the ADP-ribosylhydrolase activity of the macrodomain - a potential drug target
2018Kimberly M. Davis, PhDThe role of amoebae in enhancing the virulence of environmental human pathogens
2018Brian Garibaldi, MDEnvironmental transmission and traceability of aerosolized bio-stimulants in a clinical biocontainment unit
2017Keeve Nachman, PhDBuilding a baseline for assessing the human health impact of a landmark legislative intervention on antibiotic use in industrial poultry production
2017Sabra L. Klein, PhDIdentification of early detection biomarkers and candidate therapeutics for congenital Zika virus infection
2017Evan Bloch, MBChB, MD, MSAfrican BAOBAB (Babesia Observational Antibody) Study
2017Aaron Milstone, MDImpact of Heterogeneous Resistance Mechanisms on Hospital Transmission of Carbapenem-Resistant Enterobacteriaceae (CRE)
2016Petros Karakousis, MDIdentifying molecular targets for preventing multidrug tolerance in Mycobacterium avium infection
2016Diane Griffin, MD, PhDThe role of nsP3 in neurovirulence of chikungunya virus
2016Patricia Simner, MSc, PhDMolecular Epidemiology of Carbapenem Resistant Gram-Negative Organisms (CROs) at Johns Hopkins Hospital: Do Patients Infected with CROs Contaminate the Hospital Room Environment?
2016Brian Schwartz, MD, MSHigh-density poultry operations and associated infectious disease risks
2015Kieren Marr, MDDiagnostics for latent histoplasmosis
2015Trish Perl, MD At UT SW since 2016.The Home Environment: Infections among Patients Discharged Home with Venous Catheters
2015Margaret Kosek, MD. At UVA since 2019.Salivary diagnostics for pathogens of clinical significance in childhood environmental enteropathy
2014Pranita Tamma, MD, MHSAn evidence-based screening approach to identify children at high risk for harboring multi-drug resistant Gram-negative organisms in the PICU
2014Elizabeth Matsui, MD, MHS At UT Austin since 2018.Home Environmental Exposure to Staphylococcal Bacteria and Asthma Exacerbation
2014Christine Marie George, PhDIdentifying Environmental Transmission Routes for Shigellosis in Rural Settings using Pulsed-field Gel Electrophoresis
2014Mark Soloski, PhDImmune Events in Human Lyme Disease
2014Nicole Parrish, PhDCharacterization of β-lactam Resistance in Enterobacteriaceae Isolated from the Chesapeake Bay and Upper Watershed
2014Priya Duggal, PhD, MPHHost Genetic Susceptibility to Cryptosporidia Infection
2013Aaron Milstone, MD, MHSDevelopment and Clinical Evaluation of Laboratory Methods to Identify Reduced Antiseptic Susceptibility in Organisms Causing Healthcare Associated Infections
2013Megan Reller, MD, MPH At Duke since 2016.Detection of Unrecognized Tick-borne Febrile illness in the Upper Midwest and Northeast United States
2013Trish Perl, MD At UT SW since 2016.Clostridium difficile: Impact of colonization versus transmission on development of infection
2013Cynthia Sears, MDDoes Disruption of Host Microbiota Modify Colorectal Cancer Risk?
2013Christopher Heaney, PhDEvolutionary dynamics of multidrug-resistant Staphylococcus aureus (MDRSA), a zoonotic pathogen of clinical significance, among industrial food animal production workers